Related Experiment Videos
New frontiers in the treatment of overactive bladder and incontinence
Abstract:
In this article the author tries to forecast how urologists will treat the overactive bladder (OAB) in the next decade. He reviews drugs currently under development and also logical and exciting pharmacological targets that would be suitable targets for treating OAB in the future. The author also discusses intravesical therapy and alternative drug delivery methods, such as intravesical capsaicin and botulinum toxin. There are many advantages to advanced drug delivery systems, including the achievement of long-term therapeutic efficacy, decreased incidence and severity of side effects, and improved patient compliance. Special emphasis is placed on approaches to modulating bladder afferent nerve function to prevent OAB. Speculation on future techniques such as gene therapy can also be considered for treating OAB, because they may make it possible to access all of the genitourinary organs via minimally invasive techniques. Traditional anticholinergic therapies are limited in their effectiveness. There is great hope for future research and therapy for OAB and urinary incontinence.
Insights
Future treatments for overactive bladder (OAB) will likely involve novel drug targets and advanced delivery systems. Innovations in modulating bladder afferent nerve function and gene therapy offer promising alternatives to current OAB therapies.
Area of Science:
- Urology
- Pharmacology
- Drug Delivery Systems
Background:
- Overactive bladder (OAB) presents significant challenges with current anticholinergic therapies.
- There is a need for more effective and tolerable treatments for OAB and urinary incontinence.
Purpose of the Study:
- To forecast the future treatment landscape for overactive bladder (OAB) over the next decade.
- To review emerging pharmacological targets and advanced drug delivery methods for OAB management.
Main Methods:
- Review of drugs in development for OAB.
- Analysis of novel pharmacological targets for OAB treatment.
- Discussion of intravesical therapies and advanced drug delivery systems (e.g., capsaicin, botulinum toxin).
- Exploration of modulating bladder afferent nerve function.
- Consideration of future techniques like gene therapy.
Main Results:
- Advanced drug delivery systems offer improved efficacy, reduced side effects, and better patient compliance.
- Modulating bladder afferent nerve function is a key strategy for OAB prevention.
- Gene therapy presents a potential minimally invasive approach for genitourinary conditions.
Conclusions:
- Future OAB treatment will likely move beyond traditional anticholinergics.
- Innovations in drug delivery, nerve modulation, and gene therapy hold significant promise for managing OAB and urinary incontinence.
Related Concept Videos
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Urinary Tract Calculi III: Medical Management
Anatomy of the Genitourinary System II: Bladder and Urethra
The Micturition Reflex
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urodynamic Studies: Uroflowmetry